Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02766322 · ClinicalTrials.gov registry record

Alcohol and Bariatric Surgery

A clinical trial, sponsored by University of Illinois at Urbana-Champaign.

Terminated
Registry status
54
Enrollment target

NCT02766322 is a clinical trial that was terminated before completion, run by University of Illinois at Urbana-Champaign. The registered enrollment target is 54 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02766322 was terminated before completion, sponsored by University of Illinois at Urbana-Champaign.

TERMINATED
Registry status
54 participants
Enrollment target

Study Summary

The investigators wish to study the effects of alcohol on three forms of bariatric surgery, Roux-en-Y gastric bypass (RYGB), sleeve gastrectomy (SG) and laparoscopic adjustable gastric banding (LAGB) and compare them with a non-surgical group. The surgery is not part of the clinical trial. If insurance does not cover the procedure, then the patient is responsible for payment of the surgical process. The investigators are doing pre and post surgery testing to provide a better understanding of the effect of bariatric surgery-induced weight loss on 1) alcohol absorption, distribution and elimination from the body, 2) the effects of alcohol on mood, and 3) the effects of alcohol on driving.

Interventions

  • OTHER Oral Alcohol challenge test Alcohol visit first
  • OTHER Oral Alcohol challenge test Placebo visit first
  • OTHER Intravenous Alcohol Challenge Test (Clamp)
  • OTHER Intravenous Alcohol Self-administration Test

Trial Details

FieldValue
Enrollment Target 54 participants
Start Date 2016-03
Est. Completion 2022-05-25

What the Registry Record Tells You About NCT02766322

The ClinicalTrials.gov registry entry for NCT02766322 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Urbana-Champaign, which has 129 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 4 interventions - of which Oral Alcohol challenge test Alcohol visit first is the first listed.

NCT02766322 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02766322 about?

NCT02766322 is a clinical study titled "Alcohol and Bariatric Surgery". The investigators wish to study the effects of alcohol on three forms of bariatric surgery, Roux-en-Y gastric bypass (RYGB), sleeve gastrectomy (SG) and laparoscopic adjustable gastric banding (LAGB) and compare them with a non-surgical group. The surgery is not part of the clinical trial. If insura...

What is the current status of trial NCT02766322?

This trial is currently terminated. The enrollment target is 54 participants. The study started on 2016-03. Estimated completion is 2022-05-25.

What interventions are being tested in trial NCT02766322?

The interventions under investigation include: Oral Alcohol challenge test Alcohol visit first (OTHER), Oral Alcohol challenge test Placebo visit first (OTHER), Intravenous Alcohol Challenge Test (Clamp) (OTHER), Intravenous Alcohol Self-administration Test (OTHER).

Who is sponsoring clinical trial NCT02766322?

This trial is sponsored by University of Illinois at Urbana-Champaign, which has 129 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.